These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3370267)

  • 1. Serum dexamethasone concentrations in endogenous depressives before, during, and after treatment: preliminary observations.
    Poland RE; Rubin RT; Lesser IM
    Biol Psychiatry; 1988 Apr; 23(7):705-10. PubMed ID: 3370267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test and selection of antidepressant medications.
    Greden JF; Kronfol Z; Gardner R; Feinberg M; Mukhopadhyay S; Albala AA; Carroll BJ
    J Affect Disord; 1981 Dec; 3(4):389-96. PubMed ID: 6459354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of yohimbine and imipramine to platelets in depressive illness.
    Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K
    Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test in predicting response to tricyclic antidepressants in depressed outpatients.
    Peselow ED; Goldring N; Barouche F; Fieve RR
    Psychopathology; 1985; 18(4):206-11. PubMed ID: 4089119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine aspects of primary endogenous depression: IX. Receiver operating characteristic analysis of the dexamethasone suppression index vs. the dexamethasone suppression test in patients and controls.
    McCracken JT; Rubin RT; Poland RE
    Psychiatry Res; 1990 Jan; 31(1):49-56. PubMed ID: 2315422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients.
    Peselow ED; Goldring N; Stanley M; Barouche F; Fieve RR
    Int Clin Psychopharmacol; 1986 Jan; 1(1):17-23. PubMed ID: 3549869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls.
    Hunt GE; Johnson GF; Caterson ID
    J Affect Disord; 1989; 17(1):21-32. PubMed ID: 2525575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do serum dexamethasone levels improve the DST?
    Mossman D; Somoza E
    J Affect Disord; 1990 Sep; 20(1):13-8. PubMed ID: 2147186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors.
    Lu RB; Ho SL; Ho BT; Leu SY; Shian LR; Chen WL
    J Affect Disord; 1986; 10(3):177-84. PubMed ID: 2943770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.
    Rush AJ; Weissenburger J; Vasavada N; Orsulak PJ; Fairchild CJ
    J Clin Psychopharmacol; 1988 Dec; 8(6):421-5. PubMed ID: 3069882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
    Beckmann H; Holzmüller B; Fleckenstein P
    Acta Psychiatr Scand; 1984 Oct; 70(4):342-53. PubMed ID: 6388249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1987 Nov; 22(11):1340-8. PubMed ID: 3663786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test as a predictor of drug treatment response.
    Arató M; Rihmer Z; Szádóczky E; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):649-52. PubMed ID: 6152343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State specificity of DST abnormalities in geriatric depression.
    Meyers BS; Alpert S; Gabriele M; Kakuma T; Kalayam B; Alexopoulos GS
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):108-14. PubMed ID: 8373930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.